BioStem Technologies: Funding, Investors & Team (Sep 2026)
BioStem Technologies, Inc. is focused on promoting regenerative medicine and anti-aging methods in the USA, Europe, and Mexico. They are determined to provide premier wellness and stem cell products supported by research. Their aim is to be a leading force in the wellness industry by conducting scientific research and by producing top-quality nutraceuticals and stem cells. By possessing a cutting-edge laboratory, BioStem Technologies, Inc. takes a crucial initial step to display their commitment to enhancing well-being for the world and their investors.
BioStem Technologies has raised $2.7M across 2 funding rounds on record, the most recent an undisclosed round of $2.5M announced in May 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
BioStem Technologies Company Profile and Key Stats
Latest funding round on record: May 2026.
BioStem Technologies Funding Rounds
BioStem Technologies raised $220k in an undisclosed round announced in Apr 2023.
3.1 years later, an undisclosed round of $2.5M was announced in May 2026.
BioStem Technologies Founders and Leadership Team
Contact details for the BioStem Technologies team: 1 of 1 has an email address on file.
Start 14-day free trial →BioStem Technologies Funding Compared to Other Biotechnology Startups
BioStem Technologies' latest round of $2.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like BioStem Technologies in Biotechnology and Pompano Beach
Companies Similar to BioStem Technologies
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
BioStem Technologies Funding FAQs
What does BioStem Technologies do?
BioStem Technologies, Inc. is focused on promoting regenerative medicine and anti-aging methods in the USA, Europe, and Mexico. They are determined to provide premier wellness and stem cell products supported by research. Their aim is to be a leading force in the wellness industry by conducting scientific research and by producing top-quality nutraceuticals and stem cells. By possessing a cutting-edge laboratory, BioStem Technologies, Inc. takes a crucial initial step to display their commitment to enhancing well-being for the world and their investors.
How much funding has BioStem Technologies raised?
BioStem Technologies has raised $2.7M across 2 rounds on record. The most recent is an undisclosed round of $2.5M announced in May 2026.
When did BioStem Technologies last raise funding?
BioStem Technologies' most recent funding round on record is an undisclosed round of $2.5M, announced in May 2026.
Who founded BioStem Technologies?
FundedIQ lists Jason Matuszewski (Founder) at BioStem Technologies.
Where is BioStem Technologies headquartered?
BioStem Technologies is based in Pompano Beach, Florida, United States.
How many employees does BioStem Technologies have?
BioStem Technologies is in the 11-50 employee band.
How does BioStem Technologies' funding compare to other Biotechnology startups?
BioStem Technologies' latest round of $2.5M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's BioStem Technologies Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for BioStem Technologies is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.